Alembic Pharmaceuticals informs about company updates

06 Jun 2019 Evaluate

Alembic Pharmaceuticals has informed that the Company has received US Food & Drug Administration (USFDA) Approval for Carbidopa and Levodopa Extended-Release Tablets USP, 25 mg/100 mg and 50 mg/200 mg.

The above information is a part of company’s filings submitted to BSE.

Alembic Pharma Share Price

840.55 -11.75 (-1.38%)
29-Dec-2025 11:16 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1721.90
Dr. Reddys Lab 1263.45
Cipla 1502.25
Zydus Lifesciences 905.45
Lupin 2093.40
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×